Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis

Published:2023-06-07 Issue:21 Volume:29 Page:3362-3378
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:World J Gastroenterol

Author:

Jagirdhar Gowthami Sai Kogilathota,Qasba Rakhtan K,Pattnaik Harsha,Rama Kaanthi,Banga Akshat,Reddy Shiva Teja,Flumignan Bucharles Anna Carolina,Kashyap Rahul,Elmati Praveen Reddy,Bansal Vikas,Bains Yatinder,DaCosta Theodore,Surani Salim

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference79 articles.

1. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis

2. The negative impact of comorbidities on the disease course of COVID-19

3. Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis

4. Impact of Metabolic Syndrome on Severity of COVID-19 Illness

5. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review;World Journal of Hepatology;2024-08-27

2. Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2024-03-02

3. Association of Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease with COVID-19-Related Intensive Care Unit Outcomes: A Systematic Review and Meta-Analysis;Medicina;2023-07-03